Characteristics and oncologic outcomes of patients with Ewing sarcoma of the scapula. (September 2021)

• Record Type: Journal Article
• Authors: Yeung, Caleb M.; Kaiser, Courtney L.; Peleteiro-Pensado, Manuel; Barrientos-Ruiz, Irene; Ortiz-Cruz, Eduardo J.; Anderson, Megan E.; Raskin, Kevin A.; Lozano-Calderón, Santiago A.
• Is Part Of: Surgical oncology. Volume 38(2021)
• Publication Date: 2021-09
• Subjects: Ewing sarcoma -- Scapula -- Tumor characteristics -- Clinical characteristics -- Tumor markers; Cancer -- Surgery -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Electronic journals; 616.994059
• DOI: 10.1016/j.suronc.2021.101619
• Languages: English
• ISSNs: 0960-7404

Abstract

Abstract: Background and objectives: Ewing sarcoma is the second most common bone sarcoma of childhood. Ewing sarcomas of the scapula are rare, with little known about their characteristics and outcomes. In this study, we describe the demographic characteristics, tumor characteristics, and oncologic outcomes of patients with Ewing sarcoma of the scapula. Methods: This is a retrospective case series of thirty-four patients treated at three urban hospitals between 1993 and 2014 for Ewing sarcomas affecting the scapula. Their demographic data, tumor characteristics, and oncologic outcomes are reported and contrasted with data on Ewing sarcoma described in the literature. Results: Patients in our case series were 59% male. The average age at diagnosis was 16 years. 44% of patients had metastatic disease at presentation. 26% of patients had a tumor size >8 cm in largest dimension at diagnosis. 9 patients in our series had the t (11; 22) translocation present. Patients had a survival rate of 68% at five years. No patients had local recurrence of disease. Compared with findings reported in the literature concerning Ewing sarcoma affecting other locations, patients with Ewing sarcoma of the scapula were slightly older at time of diagnosis, had a lower percentage of tumors with size > 8 cm in largest dimension at presentation, and more commonly had metastatic disease at presentation. Patients in our cohort had a 5-year survival rate of 68%, which is higher than the rate of approximately 55% as reported in the general literature. Conclusions: In this study, we describe a retrospective case series of thirty-four patients with Ewing sarcomas of the scapula. This is the largest case series to date of Ewing sarcoma affecting this location to our knowledge. These results will contribute to the understanding of the clinical profile and oncologic behavior of Ewing sarcomas affecting the scapula. Highlights: Case series of Ewing sarcoma of the scapula treated at multiple urban hospitals. Review of the clinical presentation and course of identified cases. Tumor size, genetic translocations, tumor markers, and viability are reported. This case series data is compared to literature findings of Ewing sarcoma.